Dys-regulated activation of a Src tyroine kinase Hck at the Golgi disturbs N-glycosylation of a cytokine receptor Fms

Journal of Cellular Physiology

Volumn 221, Issue 2, 2009, Pages 458-468

  Hassan, Ranya ^a   Suzu, Shinya ^a   Hiyoshi, Masateru ^a   Takahashi Makise, Naoko ^a   Ueno, Takamasa ^a   Agatsuma, Tsutomu ^b   Akari, Hirofumi ^c   Komano, Jun ^d   Takebe, Yutaka ^d   Motoyoshi, Kazuo ^e   Okada, Seiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^e NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; HEMATOPOIETIC CELL KINASE; NEF PROTEIN; STEROID RECEPTOR COACTIVATOR 1; VASCULOTROPIN RECEPTOR 1; COLONY STIMULATING FACTOR RECEPTOR; HCK PROTEIN, HUMAN; MUTANT PROTEIN; PROTEIN KINASE INHIBITOR;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; GLYCOSYLATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PATHOGENESIS; PRIORITY JOURNAL; ALLELE; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PROTEIN BINDING; PROTEIN TRANSPORT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ALLELES; CELL LINE; ENZYME ACTIVATION; GLYCOSYLATION; GOLGI APPARATUS; HUMANS; MUTANT PROTEINS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-HCK; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 70149085247     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21878     Document Type: Article

References (48)

1. Akari H, Arold S, Fukumori T, Okazaki T, Strebel K, Adachi A. 2000. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J Virol 74:2907-2912. (Pubitemid 30117605)
2. Arold S, O'Brien R, Franken P, Strub MP, Hoh F, Dumas C, Ladbury JE. 1998. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Biochemistry 37:14683-14691. (Pubitemid 28487576)
3. Atkins KM, Thomas L, Youker RT, Harriff MJ, Pissani F, You H, Thomas G. 2008. HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: Analysis using short interfering RNA and knockout mice. J Biol Chem 283:11772-11784.
4. Bard F, Mazelin L, Pechoux-Longin C, Malhotra V, Jurdic P. 2003. Src regulates Golgi structure and KDEL receptor-dependent retrograde transport to the endoplasmic reticulum. J Biol Chem 278:46601-46606. (Pubitemid 37452235)
5. Bijlmakers MJ, Isobe-Nakamura M, Ruddock LJ, Marsh M. 1997. Intrinsic signals in the unique domain target p56lck to the plasmamembrane independently of CD4. J Cell Biol 137:1029-1040. (Pubitemid 27251039)
6. Brugge JS, Cotton PC, Queral AE, Barrett JN, Nonner D, Keane RW. 1985. Neurones express high lenels of a structurally modified, activated form of pp60c-src. Nature 316:554-557.
7. Hck-positive lysosomes. J Biol Chem 275:36223-36229.
8. Chang AH, O'Shaughnessy MV, Jirik FR. 2001. Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation. Eur J Immunol 31:2382-2387.
9. Chitu V, Stanley ER. 2006. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 18:39-48.
10. David-Pfeuty T, Nouvian-Dooghe Y. 1990. Immunolocalization of the cellular src protein in interphase and mitotic NIH c-src overexpresser cells. J Cell Biol 111:3097-3116. (Pubitemid 120034046)
11. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont , Sullivan JS, Cunningham A, Dwyer D, Mills J. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion and recipients. Science 270:988-991.
12. Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, Xu XN. 2005. HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci USA 102:11017-11022. (Pubitemid 41105985)
13. Fackler OT, Baur AS. 2002. Live and let die: Nef functions beyond HIV replication. Immunity 16:493-497.
14. Fackler OT, Wolf D, Weber HO, Laffert B, D'Aloja P, Schuler-Thurner B, Geffin R, Saksela K, Geyer M, Peterlin BM, Schuler G, Baur AS. 2001. A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells. Curr Biol 11:1294-1299. (Pubitemid 32774088)
15. Greenberg ME, Iafrate AJ, Skowronski J. 1998. The SH3 domain-binding surface and an acidic motif in HIV-1 nef regulate trafficking of class I MHC complexes. EMBO J 17:2777-2789. (Pubitemid 28227124)
16. Haller C, Rauch S, Fackler OT. 2007. HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodeling. PLoS ONE 2:e1212. (Pubitemid 351649977)
17. Hamilton JA. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8:533-544.
18. Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. 1998. Nef harbors a major determinant of pathogenicity for and AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95:163-175. (Pubitemid 28473778)
19. Hanna Z, Weng X, Kay DG, Poudrier J, Lowell C, Jolicoeur P. 2001. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is fabolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 75:9378-9392. (Pubitemid 32851942)
20. Hashimoto S, Hirose M, Hashimoto A, Morishige M, Yamada A, Hosaka H, Akagi K, Ogawa E, Oneyama C, Agatsuma T, Okada M, Kobayashi H, Wada H, Nakano H, Ikegami T, Nakagawa A, Sabe H. 2006. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci USA 103:7036-7041.
21. Hiyoshi M, Suzu S, Yoshidomi Y, Hassan R, Harada H, Sakashita N, Akari H, Motoyoshi K, Okada S. 2008. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor. Blood 111:243-250.
22. Hung CH, Thomas L, Ruby CE, Atkins KM, Morris NP, Knight ZA, Scholz I, Barklis E, Weinberg AD, Shokat KM, Thomas G. 2007. HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to down-regulate cell surface MHC-I. Cell Host Microbe 1:121-133. (Pubitemid 46554916)
23. c-src with endosomal membranes in mammalian fibroblasts. J Cell Biol 118:321-333.
24. Karkkainen S, Hiipakka M, Wang JH, Kleino I, Vaha-Jaakkola M, Renkema GH, Kiss M, Wagner R, Saksela K. 2006. Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome. EMBO Rep 7:186-191.
25. Kasahara K, Nakayama Y, Ikeda K, Fukushima Y, Matsuda D, Horimoto S, Yamaguchi N. 2004. Trafficking of Lyn through the Golgi caveolin involves the charged residues on αE and αI helices in the kinase domain. J Cell Biol 165:641-652. (Pubitemid 38765766)
26. Kestler HWIII, Ringler DJ, Mori K, Panicali DL, Sehgal PK, Daniel MD, Desrosiers RC. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
27. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. 1995. Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228-232.
28. Korade-Mirnics Z, Corey SJ. 2000. Src kinase-mediated signaling in leukocytes. J Leukocyte Biol 68:603-613.
29. Lerner EC, Smithgall TE. 2002. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo. Nat Struct Biol 9:365-369.
30. Ley SC, Marsh M, Bebbington CR, Proudfoot K, Jordan P. 1994. Distinct intracellular localization of Lck and Fyn protein tyrosine kinases in human T lymphocytes. J Cell Biol 125:639-649. (Pubitemid 24149845)
31. Lowell CA. 2004. Src-family kinases: Rheostats of immune cell signaling. Mol Immunol 41:631-643. (Pubitemid 38824619)
32. Mangasarian A, Piguet V, Wang JK, Chen YL, Trono D. 1999. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 73:1964-1973. (Pubitemid 29098098)
33. Matsuda D, Nakayama Y, Horimoto S, Kuga T, Ikeda K, Kasahara K, Yamaguchi N. 2006. Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp Cell Res 312:1205-1217.
34. Mitina O, Warmuth M, Krause G, Hallek M, Obermeier A. 2007. Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner. Ann Hematol 86:777-785. (Pubitemid 47497095)
35. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT. 1997. Activation of the Src-family tyrosine kianse Hck by SH3 domain displacement. Nature 385:650-653. (Pubitemid 27087580)
36. Oneyama C, Agatsuma T, Kanda Y, Nakano H, Sharma SV, Nakano S, Narazaki F, Tatsuta K. 2003. Synthetic inhibitors of proline-rich ligand-mediated protein-protein interaction: Potent analogs of UCS15A. Chem Biol 10:443-451. (Pubitemid 36599252)
37. Paliwal P, Radha V, Swarup G. 2007. Regulation of p73 by Hck through kinase-dependent and independent mechanisms. BMC Mol Biol 8:45. (Pubitemid 47097223)
38. Peterlin BM, Trono D. 2003. Hide, shield and strike back: How HIV-infected cells avoid immune eradication. Nat Rev Immunol 3:97-107. (Pubitemid 37328688)
39. Priceputu E, Hanna Z, Hu C, Simard MC, Vincent P, Wildum S, Schindler M, Kirchhoff F, Jolicoeur P. 2007. Primary human immunodeficiency virus type 1 Nef alleles show major differences in pathogenicity in transgenic mice. J Virol 81:4677-4693. (Pubitemid 46668665)
40. Pulvirenti T, Giannotta M, Capestrano M, Capitani M, Pisanu A, Polishchuk RS, San Pietro E, Beznoussenko GV, Mironov AA, Turacchio G, Hsu VW, Sallese M, Luini A. 2008. A traffic-activated Golgi-based signaling circuit coordinates the secretory pathway. Nat Cell Biol 10:912-922.
41. Roeth JF, Collins KL. 2006. Human immunodeficiency virus type 1 Nef: Adapting to intracellular trafficking pathways. Mol Biol Rev 70:548-563. (Pubitemid 43895037)
42. + viruses but not for down-regulation of CD4. EMBO J 14:484-491.
43. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2:338-342. (Pubitemid 26080655)
44. Suzu S, Tanaka-Douzono M, Nomaguchi K, Yamada M, Hayasawa K, Kimura F, Motoyoshi K. 2000. p56dok-2 as a cytokine-inducible inhibitor of cell proliferation and signal transduction. EMBO J 19:5114-5122. (Pubitemid 30765250)
45. Suzu S, Harada H, Matsumoto T, Okada S. 2005. HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities. Blood 105:3230-3237. (Pubitemid 40504344)
46. Trible RP, Emert-Sedlak L, Smithgall TE. 2006. HIV-1 Nef selecyively activates Src family kinases Hck, Lyn, and c-Src through SH3 domain interaction. J Biol Chem 281:27029-27038. (Pubitemid 44401731)
47. Ueno T, Motozono C, Dohki S, Mwimanzi P, Rauch S, Fackler OT, Oka S, Takiguchi M. 2008. CTL-mediated selective pressure influences dynamic evolution and pathogenetic functions of HIV-1 Nef. J Immunol 180:1107-1116.
48. 2-terminal myristoylation and palmitoylation at cysteine-3. J Cell Biol 136:1023-1035.